Acadian Asset Management
CRNX icon

Acadian Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Acadian Asset Management’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,717
Closed -$241K – 1728
2024
Q3 		$241K Buy
+4,717
New +$241K ﹤0.01% 1299